“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment
Positive results from moderate-to-severe atopic dermatitis trial
Centessa Pharmaceuticals to be acquired by Lilly
Smart drugs to fight cancer
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
Positive results from phase 1 Huntington’s disease trial
Potential for drug targeting BDCA2 and TACI
CCHF in the crosshairs
Kalexo Bio formed to advance siRNA therapy for cardiovascular disorders
First liquid ambient temperature stable qPCR master mixes
Lilly to build $5bn manufacturing facility in Virginia
IND clearance for long QT syndrome treatment